EQUINOX NEPREMICNINE d.d. Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '25 Apr 10, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	105	101	94	90	-
Market Cap Growth	7.44%	7.44%	4.88%	-	-
Enterprise Value	112	109	99	96	-
Last Close Price	58.50	56.50	50.94	47.14	-
PE Ratio	97.50	94.50	108.24	125.98	-
PS Ratio	12.05	11.66	12.08	12.21	-
PB Ratio	2.75	2.66	2.36	2.17	-
P/OCF Ratio	16.44	15.90	16.49	10.82	-
EV/Sales Ratio	12.96	12.59	12.71	13.06	-
EV/EBITDA Ratio	26.46	25.71	23.97	19.93	-
EV/EBIT Ratio	-	348.46	269.49	68.35	-
Debt / Equity Ratio	0.22	0.22	0.22	0.35	0.35
Debt / EBITDA Ratio	1.93	1.93	2.15	3.03	3.60
Asset Turnover	0.17	0.17	0.14	0.13	-
Quick Ratio	0.98	0.98	3.15	1.78	5.39
Current Ratio	0.98	0.98	3.15	1.78	5.65
Return on Equity (ROE)	2.75%	2.75%	2.14%	1.75%	-
Return on Assets (ROA)	0.37%	0.37%	0.40%	1.52%	-
Return on Capital (ROIC)	0.41%	0.41%	0.44%	1.60%	-
Earnings Yield	102.33%	1.06%	0.92%	0.79%	-
Dividend Yield	288.88%	-	3.32%	3.03%	-
Payout Ratio	28282.13%	282.82%	295.15%	-	-
Buyback Yield / Dilution	155.00%	1.55%	-1.73%	-	-
Total Shareholder Return	443.88%	1.55%	1.59%	3.03%	-

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.